InsidersTradesSigma
Follow the OCULAR THERAPEUTIX, INC. share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was disclosed on 31 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: DONALD D NOTMAN JR.. Every trade is openly available.
Analysts rate OCULAR THERAPEUTIX, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
OCULAR THERAPEUTIX, INC. is a biopharmaceutical company focused on developing innovative treatments for eye diseases. It is listed on the NASDAQ under the symbol OCUL.